Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy

Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is a rare X-linked recessive disease caused by deficiency of the lysosomal enzyme iduronate-2-sulphatase, leading to progressive accumulation of glycosaminoglycans in nearly all cell types, tissues and organs. Clinical manifestations include se...

Descripción completa

Detalles Bibliográficos
Autores principales: Wraith, J. Edmond, Scarpa, Maurizio, Beck, Michael, Bodamer, Olaf A., De Meirleir, Linda, Guffon, Nathalie, Meldgaard Lund, Allan, Malm, Gunilla, Van der Ploeg, Ans T., Zeman, Jiri
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234442/
https://www.ncbi.nlm.nih.gov/pubmed/18038146
http://dx.doi.org/10.1007/s00431-007-0635-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2234442/
https://www.ncbi.nlm.nih.gov/pubmed/18038146
http://dx.doi.org/10.1007/s00431-007-0635-4

Ejemplares similares